TipRanks
Go Ultimate55% OFF

Chemring (CMN1) Price & Analysis

CMN1 Stock Chart & Stats

€6.72-€0.06(-0.89%)
At close: 4:00 PM EDT
EUR 6EUR 6.5EUR 721 Aug25 Aug24 Sep15 Oct30 Oct
Day’s Range
EUR 6.72 - EUR 6.95
52-Week Range
EUR 5.15 - EUR 7.47
Previous Close
EUR 6.78
Volume
0
Average Volume (3M)
41
Market Cap
EUR 1.83B
Enterprise Value
EUR 1.59B
Total Cash (Recent Filing)
EUR 44.70M
Total Debt (Recent Filing)
EUR 189.20M
Price to Earnings (P/E)
46.3
Beta
1.10
Next Earnings
Dec 08, 2026
Next Dividend Ex-Date
N/A
Dividend Yield
1.44%

Bulls Say, Bears Say

Bulls Say

Improving Profitability

Improved net, EBIT, and EBITDA margins indicate stronger operating efficiency and profitability in the core business. If maintained, this gives Chemring greater capacity to reinvest in defence programmes, absorb cost pressure, and convert revenue into sustainable earnings over the coming quarters.

Manageable Leverage

Moderate leverage and a substantial equity funding base provide financial resilience for a defence supplier exposed to programme timing. Healthy return on equity also suggests capital is being deployed effectively, while the balance sheet should preserve flexibility for investment and contract execution.

Multi-Year Defence Programmes

Chemring’s exposure to government customers, framework agreements, and multi-year defence programmes can support recurring demand beyond individual product deliveries. Countermeasure replenishment, training consumption, upgrades, and through-life services may reinforce customer relationships and improve revenue visibility.

Bears Say

Revenue Contraction

The revenue decline indicates that stronger margins are not currently being supported by top-line expansion. Continued contraction could limit operating leverage, reduce the scale available to fund research and programme investment, and make earnings more dependent on efficiency gains rather than business growth.

Sharp Free Cash Flow Deterioration

The sharp deterioration in free cash flow weakens the quality and flexibility of reported earnings, even though operating cash flow was strong relative to net income. Persistent cash conversion pressure could constrain internally funded investment, debt reduction, and shareholder distributions.

Declining Earnings Per Share

A material decline in EPS signals that earnings available per share are under pressure despite improved reported margins. If the trend persists, it could indicate that profitability gains are not offsetting weaker revenue or other factors, reducing the durability of shareholder-level earnings growth.

Chemring News

CMN1 FAQ

What was Chemring’s price range in the past 12 months?
Chemring lowest stock price was €5.15 and its highest was €7.47 in the past 12 months.
What is Chemring’s market cap?
Chemring’s market cap is €1.83B.
When is Chemring’s upcoming earnings report date?
Chemring’s upcoming earnings report date is Dec 08, 2026 which is in 37 days.
How were Chemring’s earnings last quarter?
Chemring released its earnings results on Jun 02, 2026. The company reported €0.073 earnings per share for the quarter.
Is Chemring overvalued?
According to Wall Street analysts Chemring’s price is currently Undervalued.
Does Chemring pay dividends?
Chemring does not currently pay dividends.
What is Chemring’s EPS estimate?
Chemring’s EPS estimate is 0.16.
How many shares outstanding does Chemring have?
Chemring has 272,126,800 shares outstanding.
What happened to Chemring’s price movement after its last earnings report?
Chemring reported an EPS of €0.073 in its last earnings report. Following the earnings report the stock price went down -5.493%.
Which hedge fund is a major shareholder of Chemring?
Currently, no hedge funds are holding shares in DE:CMN1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology